Search

everythinglearnresearchcommunity

for

Search:↓

More prostate biopsies increase the chance of finding cancers that may not need treatment.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

% free PSA and urinary markers help better identify prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Finasteride significantly reduces prostate cancer risk.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Large prostates link to more hair loss.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.